RIBOLIFE-B (06938) spent HKD 958,700 to repurchase 16,600 shares on September 8.
Rebio Biotech-B (06938) announced that on September 8, 2026, it spent HKD 958,700 to repurchase 16,600 shares.
RIBOLIFE-B (06938) announced that on September 8, 2026, it spent HK$958,700 to repurchase 16,600 shares.
Related Articles
ALEBUND-B(09637): The clinical trial application for AP308, a new drug for the treatment of IgA nephropathy, has been approved by the U.S. Food and Drug Administration.
ANHUIEXPRESSWAY (00995) nominates Pan Ping as a candidate for independent non-executive director.
Xinke Mobile (688387.SH) has had its application for the issuance of A-shares to specific investors accepted by the Shanghai Stock Exchange.
ALEBUND-B(09637): The clinical trial application for AP308, a new drug for the treatment of IgA nephropathy, has been approved by the U.S. Food and Drug Administration.
ANHUIEXPRESSWAY (00995) nominates Pan Ping as a candidate for independent non-executive director.
Xinke Mobile (688387.SH) has had its application for the issuance of A-shares to specific investors accepted by the Shanghai Stock Exchange.
RECOMMEND
